US stock momentum indicators and trend analysis strategies for capturing strong directional moves in the market for profit maximization. Our momentum research identifies stocks that are showing the strongest price appreciation and fundamental improvement in their business. We provide momentum scores, relative strength rankings, and trend following tools for comprehensive momentum analysis. Capture momentum with our comprehensive analysis and strategic indicators designed for trend-following strategies.
This neutral financial analysis evaluates Biogen Inc.’s (BIIB) recently announced up to $850 million licensing deal with TJ Biopharma for exclusive Greater China commercial rights and global development rights to felzartamab, an anti-CD38 immunotherapy candidate targeting relapsed/refractory multipl
Biogen Inc. (BIIB) - Acquires Felzartamab Greater China Rights to Challenge Janssen's Darzalex Multiple Myeloma Dominance - Trending Momentum Stocks
BIIB - Stock Analysis
4214 Comments
533 Likes
1
Keandria
Regular Reader
2 hours ago
I don’t know why but I feel late again.
👍 37
Reply
2
Amanita
Registered User
5 hours ago
Really wish I had seen this before. 😓
👍 162
Reply
3
Hazele
Daily Reader
1 day ago
This gave me unnecessary confidence.
👍 182
Reply
4
Loreene
Registered User
1 day ago
Useful overview for understanding risk and reward.
👍 30
Reply
5
Tylre
Experienced Member
2 days ago
Concise insights that provide valuable context.
👍 219
Reply
© 2026 Market Analysis. All data is for informational purposes only.